ArticleJournal of translational medicine2021

TRPC3, but not TRPC1, as a good therapeutic target for standalone or complementary treatment of DMD.

Anna Creisméas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.